• Jeffrey Coleman, Ph.D., represents clients in complex, high-stakes patent litigation. He advises patent owners seeking to enforce their rights and companies defending against allegations of patent infringement. Jeffrey advises clients on matters related to a diverse array of technologies, including small molecule pharmaceuticals, biologics, vaccines and vaccine formulations, medical devices, DNA/RNA technology, and molecular diagnostics. He also counsels companies on the development and commercialization of patents and patent portfolios, freedom to operate, and patent licensing.

    Jeffrey handles all facets of patent litigation, including pre-suit analysis and investigation, fact and expert discovery, depositions, technical reports, Markman and summary judgment proceedings, and trial. He also has experience coordinating U.S. patent litigation proceedings with parallel ex-U.S. litigations. Jeffrey also has experience in inter partes review proceedings, and proceedings before the U.S. International Trade Commission.

    Jeffrey also dedicates significant time to pro bono work. He has assisted veterans seeking disability benefits and immigrants seeking to become naturalized U.S. citizens. 

    Credentials

    Education

    • J.D., cum laude, Fordham University School of Law, 2014
      • Executive Notes Editor, Fordham Law Review
    • Ph.D., Molecular Toxicology, Pennsylvania State University, 2010
    • B.S., Chemistry, Ursinus College, 2003

    Bar Admissions

    • New York, 2015

    Court Admissions

    • U.S.D.C., Southern District of New York
    • U.S.D.C., Eastern District of New York

    Professional Affiliations

    • American Bar Association
    • New York Intellectual Property Law Association
      • Officer and member of the Board of Directors, May 2023 – Present 
      • Co-Chair, Amicus Briefs Committee, May 2022 – May 2023
    • New York State Bar Association

    Focus Areas

  • Perspectives

    • Articles
      Jan. 10, 2023
      Exploring The Amgen Genus Claims Headed To High Court
      Read More
    • Speaking Engagement
      Nov. 09, 2022
      New York Intellectual Property Law Association’s One-Day Patent CLE Seminar
      Read More